Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Terlipressin: Important Safety Information from Ferring Ireland Limited as approved by the HPRA (15.12.22)
Notice type:
3rd Party Publications
Date:
21/12/2022
Problem Or Issue:
Important Safety Information from Ferring Ireland Limited regarding Terlipressin: Serious or fatal respiratory failure and sepsis/septic shock in patients with type 1 hepatorenal syndrome (type 1 HRS)
Important Safety Information – Terlipressin
« Back
Date Printed: 26/04/2024